City: Santo André
See other companies with research projects supported by PIPE ProgramKRABS Biotechnology is a startup that works with the development of new chimeric monoclonal antibodies (qmAb) for therapeutic applications and diagnoses. These compounds, when properly selected, are identical to monoclonal antibodies in terms of affinity, selectivity, and specificity. Our first product is related to the inhibition of a protease from the kallikrein family, crucial in the d…
Our company focuses on the development of inhibitors for kallikreins involved in the epidermal desquamation process. Recent discoveries showing the importance of kallikreins in skin diseases, and the potential therapeutic use of kallikrein inhibitors for dermatological disorders, is the backbone that guides our business. In addition, our company also seeks to develop methodologies for the…
| 2 / 2 | Completed research grants |
| Associated processes | |
Carregando Filtros. Aguarde...
Left-click and hold. Drag the cursor on the map until you see the view you want.
Select year: |
Show years by sequential order |